|
Extramural Support
|
RMS2014 [E]
|
$298,831,922
|
$1,830,266
|
N/A
|
National Institutes of Health
|
|
Glycomics Laboratory for the Early Detection of Epithelial Ovarian Cancer
|
5U01CA168870-03
|
$439,135
|
$439,135
|
ABBOTT, KAREN
|
UNIV OF ARKANSAS FOR MED SCIS
|
|
Platelets promote growth of ovarian cancer
|
5R01CA177909-02
|
$322,040
|
$322,040
|
AFSHAR-KHARGHAN, VAHID
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
1U10CA180791-01
|
$737,200
|
$14,744
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Naional Cancer Institute, Naitonal Clinical Trials Network U10 Lead Academic Sit
|
1U10CA180790-01
|
$1,439,850
|
$28,797
|
ALBERTS, STEVEN
|
MAYO CLINIC ROCHESTER
|
|
Consolidated Basic Cancer Research Program
|
2P30CA010815-45
|
$2,516,380
|
$276,802
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-45S1
|
$92,630
|
$10,189
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
NCTN Deep South Research Consortium
|
1U10CA180855-01
|
$497,800
|
$74,670
|
ALVAREZ, RONALD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$709,489
|
$70,949
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
COMBINATORIAL-DESIGNED NANO-PLATFORMS TO OVERCOME TUMOR DRUG RESISTANCE
|
5U01CA151452-05
|
$400,638
|
$200,319
|
AMIJI, MANSOOR
|
NORTHEASTERN UNIVERSITY
|
|
The University of Kentucky Cancer Nanotechnology Training Center (UK CNTC)
|
5R25CA153954-05
|
$313,570
|
$62,714
|
ANDERSON, BRADLEY
|
UNIVERSITY OF KENTUCKY
|
|
Women's Health Initiative Cancer Survivor Cohort
|
5UM1CA173642-02
|
$2,232,714
|
$357,234
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Nuclear Factor-kappaB in Ovarian Cancer
|
ZIA BC 011054
|
$618,864
|
$618,864
|
Annunziata, Christina
|
CCR (NCI)
|
|
Clinical trials in women's cancers
|
ZIA BC 011584
|
$165,030
|
$123,773
|
Annunziata, Christina
|
CCR (NCI)
|
|
Mechanisms of Chromosomal Translocation
|
ZIA SC 010379
|
$190,546
|
$38,109
|
Aplan, Peter
|
CCR (NCI)
|
|
Hutchinson Center as Lead Academic Participating Site (U10)
|
1U10CA180828-01
|
$656,150
|
$32,808
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S5
|
$10,116,159
|
$202,323
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S6
|
$75,000
|
$1,500
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S7
|
$122,667
|
$2,453
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells
|
ZIA BC 011197
|
$450,042
|
$225,021
|
Appella, Ettore
|
CCR (NCI)
|
|
The BARD1 tumor suppressor and breast cancer
|
5R01CA172272-02
|
$322,040
|
$161,020
|
BAER, RICHARD
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Dartmouth Center for Cancer Nanotechnology Excellence
|
5U54CA151662-05
|
$2,104,832
|
$694,595
|
BAKER, IAN
|
DARTMOUTH COLLEGE
|
|
CD4+ Memory T-Cells in Human Tumor Microenvironment
|
5R01CA108970-10
|
$287,818
|
$259,036
|
BANKERT, RICHARD
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
|
Re-activating Memory T Cells in the Microenvironment of Human Tumors
|
5R01CA131407-07
|
$319,024
|
$319,024
|
BANKERT, RICHARD
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
|
Washington University/ Siteman Cancer Center Lead Academic Site
|
1U10CA180833-01
|
$1,548,433
|
$116,132
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
The University of Texas M. D. Anderson Cancer Center SPORE in Ovarian Cancer
|
5P50CA083639-15
|
$2,093,826
|
$2,093,826
|
BAST, ROBERT
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Cancer Center Support Grant
|
3P30CA006516-49S1
|
$118,825
|
$4,753
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-49S2
|
$75,000
|
$3,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA006516-49S3
|
$12,500
|
$500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
5P30CA006516-49
|
$10,827,666
|
$433,107
|
BENZ, EDWARD
|
DANA-FARBER CANCER INST
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA022453-32S1
|
$75,000
|
$3,750
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA022453-32
|
$2,459,346
|
$122,967
|
BEPLER, GEROLD
|
WAYNE STATE UNIVERSITY
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
1U10CA180847-01
|
$587,562
|
$29,378
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY
|
|
Breast and Other Cancers in the California Teachers Cohort
|
5R01CA077398-16
|
$2,424,791
|
$242,479
|
BERNSTEIN, LESLIE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Bmi-1, a potential therapeutic target in ovarian cancer
|
5R01CA157481-03
|
$302,136
|
$302,136
|
BHATTACHARYA, RESHAM
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
JHU ICMIC Program
|
5P50CA103175-09
|
$1,453,060
|
$58,122
|
BHUJWALLA, ZAVER
|
JOHNS HOPKINS UNIVERSITY
|
|
Novel Biomarkers in Ovarian Cancer
|
5R01CA142832-05
|
$337,135
|
$337,135
|
BIRRER, MICHAEL
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
The FGF18/FGFR4 amplicon: Novel therapeutic biomarkers for ovarian cancer
|
5R01CA169200-02
|
$360,890
|
$360,890
|
BIRRER, MICHAEL
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Genetic Risk Prediction in Primary Care
|
5R03CA173834-02
|
$80,031
|
$40,016
|
BISWAS, SWATI
|
UNIVERSITY OF TEXAS DALLAS
|
|
SWOG Network Group Operations Center of the NCTN
|
1U10CA180888-01
|
$13,829,118
|
$1,382,912
|
BLANKE, CHARLES
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Training of Academic Gynecologic Oncologists
|
5T32CA101642-09
|
$407,137
|
$134,355
|
BODURKA, DIANE
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Oncogenic Met Signaling in Urologic Malignancies
|
ZIA BC 011124
|
$333,956
|
$16,698
|
Bottaro, Donald
|
CCR (NCI)
|
|
Johns Hopkins University NCTN Lead Academic Site Program
|
1U10CA180802-01
|
$639,550
|
$31,978
|
BRAHMER, JULIE
|
JOHNS HOPKINS UNIVERSITY
|
|
Diagnostic Utility of Culdocentesis in Patients with a Suspicious Adnexal Mass
|
1R03CA181907-01
|
$73,750
|
$73,750
|
BRARD, LAURENT
|
SOUTHERN ILLINOIS UNIVERSITY SCH OF MED
|
|
Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy
|
ZIA SC 006353
|
$787,803
|
$157,561
|
Brechbiel, Martin
|
CCR (NCI)
|
|
Metal Chelate Conjugated Dendrimer Constructs for Diagnosis and Therapy
|
ZIA SC 010051
|
$424,202
|
$84,840
|
Brechbiel, Martin
|
CCR (NCI)
|
|
GOG Studies
|
ZIA CP010126 - 01068
|
$57,192
|
$11,438
|
Brinton, Louise
|
DCEG (NCI)
|
|
Columbia Missouri serum bank participant extended follow-up
|
ZIA CP010126 - 01103
|
$152,184
|
$15,218
|
Brinton, Louise
|
DCEG (NCI)
|
|
Infertility follow-up study: 1965-88
|
ZIA CP010128 - 01082
|
$111,489
|
$33,447
|
Brinton, Louise
|
DCEG (NCI)
|
|
Multiplexed Ovarian Cancer Microfluidic Tissue Microarray
|
1R43CA177146-01A1
|
$225,000
|
$225,000
|
BROOKS, BENJAMIN
|
WASATCH MICROFLUIDICS
|
Total relevant funding to Ovarian Cancer for this search: $91,524,537
|